Erdafitinib (JNJ-42756493) [1346242-81-6]

Selleck Chemicals

Erdafitinib (JNJ-42756493) [1346242-81-6]

9

Research Use Only

Erdafitinib (JNJ-42756493) is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Erdafitinib also binds to RET (c-RET), CSF-1R, PDGFR-alfa/PDGFR-bèta, FLT4, Kit (c-Kit) and VEGFR-2 and induces cellular apoptosis.

12352200